Finally, the data suggested that simultaneous application of Trx-1 inhibitors and radiotherapy might ameliorate clinical outcomes of patients with CRC with low ALDH1L2 levels [121]. The gene discussed is ALDH1L2; the disease is colorectal carcinoma.